share_log

Canaccord Genuity Maintains Buy on Inari Medical, Maintains $75 Price Target

Canaccord Genuity Maintains Buy on Inari Medical, Maintains $75 Price Target

Canaccord Genuity維持對Inari Medical的買入,維持75美元的目標股價
Benzinga ·  04/12 12:00

Canaccord Genuity analyst William Plovanic maintains Inari Medical (NASDAQ:NARI) with a Buy and maintains $75 price target.

Canaccord Genuity分析師威廉·普洛瓦尼奇維持伊納裏醫療(納斯達克股票代碼:NARI)的買入並維持75美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論